Screener
Haemonetics HAE Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's retained earnings?
- Haemonetics (HAE) reported retained earnings of $311.52M in Q2 2026.
- How has Haemonetics's retained earnings changed year-over-year?
- Haemonetics's retained earnings decreased by 12.5% year-over-year, from $356.05M to $311.52M.
- What is the long-term trend for Haemonetics's retained earnings?
- Over 5 years (2021 to 2026), Haemonetics's retained earnings has grown at a 12.1% compound annual growth rate (CAGR), from $157.98M to $279.34M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Haemonetics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude